Increase/Decrease in Cash (Quarterly)

Increase/Decrease in Cash: The total change in cash for the company over the given period.

Teva Pharmaceutical Industries Ltd. (TEVA) had Increase/Decrease in Cash of $-1.10B for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$4.48B
Net Income	$433.00M
Cost of Goods Sold	$2.18B
Gross Profit	$2.30B
Operating Expenses	$3.60B
Operating Income	$882.00M
Non-Operating Income/Expense	$-237.00M
Pre-Tax Income	$646.00M
Normalized Pre-Tax Income	$646.00M
Income after Taxes	$432.00M
Income from Continuous Operations	$434.00M
Consolidated Net Income/Loss	$434.00M
Normalized Income after Taxes	$432.00M
EBIT	$882.00M
EBITDA	$1.13B
Weighted-Average Shares Outstanding (Basic)	1.15B
Weighted-Average Shares Outstanding (Diluted)	1.16B
Earnings per Share (EPS) (Basic)	$0.38
Earnings per Share (EPS) (Diluted)	$0.37
Balance Sheet Financials
Current Assets	$12.74B
Property, Plant, and Equipment	$4.82B
Long-Term Assets	$27.12B
Total Assets	$39.86B
Current Liabilities	$11.49B
Long-Term Debt	$16.77B
Long-Term Liabilities	$21.11B
Total Liabilities	$32.60B
Common Equity	$7.25B
Tangible Shareholders Equity	$-12.63B
Shareholders Equity	$7.25B
Common Shares Outstanding	1.15B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$491.00M
Cash Flow from Investing Activities	$572.00M
Cash Flow from Financial Activities	$-2.19B
Beginning Cash	$3.30B
End Cash	$2.20B
Increase/Decrease in Cash	$-1.10B
Stock-Based Compensation	$106.00M
Common Stock Dividends Paid	$-340.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.11
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.70
Debt to Equity Ratio	2.31
Gross Margin	51.43%
Operating Margin	19.69%
EBIT Margin	19.69%
EBITDA Margin	--
Pre-Tax Profit Margin	14.42%
Profit Margin	9.67%
Free Cash Flow	$166.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	0.65
Receiveable Turnover	1.18
Days Sales in Receivables	76.54
Return on Equity	5.98%
Return on Tangible Equity	-3.44%
Return on Assets	1.09%
Return on Investments	1.81%
Book Value Per Share	$6.32
Free Cash Flow per Share	$0.14
Operating Cash Flow per Share	$0.42

Data from Zacks Investment Research, Inc.